NAT2 and neoplasm: The chi-square test indicated that NAT2 expression was negatively related to tumor differentiation and AJCC stage in CRC (p = 0.03 and p = 0.02, respectively; Table 1), which was confirmed by GSE17538 expression profiling (Supplementary Table S2).